Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Which credit card gives the best rewards for travel? Discover top cards that offer excellent travel rewards and benefits.
23,522 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...
SPYM has crossed the $150 billion mark in assets under management, underscoring a shift toward low-cost, broad-market...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Thursday brought a standout moment for investors tracking stock splits. A dedicated stock-split service captured atte...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Looking ahead two decades can feel daunting, but some stocks stand out as reliable winners. This guide reveals three ...
Bitcoin still dominates headlines, but Ethereum’s evolving ecosystem and staking potential offer a compelling longer-...
June brought a sharp turn for Newmont as gold dynamics and costs collided with production headwinds. This article bre...